1-20 of 24
Quynh-Thu Le
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer

Li Guan, Pedro A. Torres-Saavedra, Xiaobei Zhao, Michael B. Major, Brittany J. Holmes, Ngan K. Nguyen, Parasakthy Kumaravelu, Tim Hodge, Maximilian Diehn, Jose Zevallos, F. Christopher Holsinger, Bahman Emami, Richard C. Jordan, Michele C. Hayward, Stephen M. Sagar, William Morrison, Christopher Schultz, Jimmy J. Caudell, Christopher U. Jones, Scott V. Bratman, Thomas J. Galloway, Daniel J. Ma, Sue S. Yom, Mahesh Kudrimoti, Harold E. Kim, Jonathan Harris, Quynh-Thu Le, D. Neil Hayes
Journal: Clinical Cancer Research
Clin Cancer Res OF1–OF10.
https://doi.org/10.1158/1078-0432.CCR-24-2334
Published: 07 January 2025
View article titled, Association between Locoregional Failure and <em>NFE2L2/KEAP1/CUL3</em> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer
Open the PDF for Association between Locoregional Failure and <em>NFE2L2/KEAP1/CUL3</em> Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract PO-066: Relationship between KEAP1/NFE2L2 pathway activation and radiation resistance in oral cavity cancer

Li Guan, Hongbin Cao, Angela Hui, Shirley Kwok, Vignesh Viswanathan, Dhanya Nambiar, Rie V. Eyben, Brittany Holmes, Christina Kong, Maximilian Diehn, Quynh-Thu Le
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-066.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-066
Published: 15 April 2021
View article titled, Abstract PO-066: Relationship between <em>KEAP1/NFE2L2</em> pathway activation and radiation resistance in oral cavity cancer
Journal Articles

Abstract PO-048: VISTA immune-checkpoint blunts radiotherapy induced anti-tumor immune response

Dhanya K. Nambiar, Nishant Mehta, Sainiteesh Maddineni, Hongbin Cao, Vignesh Viswanathan, Tia Cheunkarndee, Jennifer R. Cochran, Quynh Thu Le
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (8_Supplement): PO-048.
https://doi.org/10.1158/1557-3265.RADSCI21-PO-048
Published: 15 April 2021
View article titled, Abstract PO-048: VISTA immune-checkpoint blunts radiotherapy induced anti-tumor immune response
Journal Articles

Induced Tumor Heterogeneity Reveals Factors Informing Radiation and Immunotherapy Combinations

Todd A. Aguilera, Eslam A. Elghonaimy, Hussein Shehade, Marjan Rafat, Laura Castellini, Dadi Jiang, Mihalis Kariolis, Albert C. Koong, Quynh-Thu Le, Lesley G. Ellies, Erinn B. Rankin, Edward E. Graves, Amato J. Giaccia
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12): 2972–2985.
https://doi.org/10.1158/1078-0432.CCR-19-4220
Published: 15 June 2020
View article titled, Induced Tumor Heterogeneity Reveals Factors Informing Radiation and Immunotherapy Combinations
Open the PDF for Induced Tumor Heterogeneity Reveals Factors Informing Radiation and Immunotherapy Combinations in another window
Includes: Supplementary data
Journal Articles

Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer

Loren K. Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, David I. Rosenthal, Kaveh Zakeri, Lucas K. Vitzthum, Steven J. Frank, Peter B. Schiff, Andy M. Trotti, III, James A. Bonner, Christopher U. Jones, Sue S. Yom, Wade L. Thorstad, Stuart J. Wong, George Shenouda, John A. Ridge, Qiang E. Zhang, Quynh-Thu Le
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (23): 7078–7088.
https://doi.org/10.1158/1078-0432.CCR-19-1832
Published: 02 December 2019
View article titled, Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer
Open the PDF for Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract IA16: Midtreatment metabolic imaging as a biomarker of treatment response

Quynh-Thu Le
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (23_Supplement): IA16.
https://doi.org/10.1158/1557-3265.AACRAHNS17-IA16
Published: 30 November 2017
View article titled, Abstract IA16: Midtreatment metabolic imaging as a biomarker of treatment response
Journal Articles

Abstract 62: Loss of PERP p53/p63 target gene may indicate tumorigenesis at the margin and local recurrence

Amanda Simmons, Christina Kong, Rie von Eyben, Laura Attardi, Xiaohui Ma, Quynh-Thu Le, Cherie-Ann Nathan
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (23_Supplement): 62.
https://doi.org/10.1158/1557-3265.AACRAHNS17-62
Published: 30 November 2017
View article titled, Abstract 62: Loss of PERP p53/p63 target gene may indicate tumorigenesis at the margin and local recurrence
Journal Articles

SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells

Hiroyuki Ozawa, Ruchira S. Ranaweera, Evgeny Izumchenko, Eugene Makarev, Alex Zhavoronkov, Elana J. Fertig, Jason D. Howard, Ana Markovic, Atul Bedi, Rajani Ravi, Jimena Perez, Quynh-Thu Le, Christina S. Kong, Richard C. Jordan, Hao Wang, Hyunseok Kang, Harry Quon, David Sidransky, Christine H. Chung
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (17): 5162–5175.
https://doi.org/10.1158/1078-0432.CCR-16-1686
Published: 31 August 2017
View article titled, SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells
Open the PDF for SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Emerging Treatment Paradigms in Radiation Oncology

Quynh-Thu Le, Hiroki Shirato, Amato J. Giaccia, Albert C. Koong
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (15): 3393–3401.
https://doi.org/10.1158/1078-0432.CCR-14-1191
Published: 02 August 2015
View article titled, Emerging Treatment Paradigms in Radiation Oncology
Open the PDF for Emerging Treatment Paradigms in Radiation Oncology in another window
Includes: Supplementary data
Journal Articles

Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response

Peiwen Kuo, Scott V. Bratman, David B. Shultz, Rie von Eyben, Cato Chan, Ziwei Wang, Carmen Say, Aparna Gupta, Bill W. Loo, Jr, Amato J. Giaccia, Albert C. Koong, Maximilian Diehn, Quynh-Thu Le
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (21): 5558–5569.
https://doi.org/10.1158/1078-0432.CCR-14-1138
Published: 30 October 2014
View article titled, Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response
Open the PDF for Galectin-1 Mediates Radiation-Related Lymphopenia and Attenuates NSCLC Radiation Response in another window
Includes: Supplementary data
Journal Articles

A Novel Aldehyde Dehydrogenase-3 Activator (Alda-89) Protects Submandibular Gland Function from Irradiation without Accelerating Tumor Growth

Nan Xiao, Hongbin Cao, Che-Hong Chen, Christina S. Kong, Rehan Ali, Cato Chan, Davud Sirjani, Edward Graves, Albert Koong, Amato Giaccia, Daria Mochly-Rosen, Quynh-Thu Le
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (16): 4455–4464.
https://doi.org/10.1158/1078-0432.CCR-13-0127
Published: 13 August 2013
View article titled, A Novel Aldehyde Dehydrogenase-3 Activator (Alda-89) Protects Submandibular Gland Function from Irradiation without Accelerating Tumor Growth
Open the PDF for A Novel Aldehyde Dehydrogenase-3 Activator (Alda-89) Protects Submandibular Gland Function from Irradiation without Accelerating Tumor Growth in another window
Includes: Supplementary data
Journal Articles

An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma

Quynh-Thu Le, Qiang Zhang, Hongbin Cao, Ann-Joy Cheng, Benjamin A. Pinsky, Ruey-Long Hong, Joseph T. Chang, Chun-Wei Wang, Kuo-Chien Tsao, YM Dennis Lo, Nancy Lee, K. Kian Ang, Anthony T.C. Chan, K.C. Allen Chan
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (8): 2208–2215.
https://doi.org/10.1158/1078-0432.CCR-12-3702
Published: 15 April 2013
View article titled, An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma
Open the PDF for An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma in another window
Includes: Supplementary data
Journal Articles

Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer

Quynh-Thu Le, Richard Fisher, Kelly S. Oliner, Richard J. Young, Hongbin Cao, Christina Kong, Edward Graves, Rodney J. Hicks, Grant A. McArthur, Lester Peters, Brian O'Sullivan, Amato Giaccia, Danny Rischin
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1798–1807.
https://doi.org/10.1158/1078-0432.CCR-11-2094
Published: 14 March 2012
View article titled, Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer
Open the PDF for Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial

Annette M. Lim, Danny Rischin, Richard Fisher, Hongbin Cao, Kathleen Kwok, Daniel Truong, Grant A. McArthur, Richard J. Young, Amato Giaccia, Lester Peters, Quynh-Thu Le
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (1): 301–307.
https://doi.org/10.1158/1078-0432.CCR-11-2295
Published: 02 January 2012
View article titled, Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial
Open the PDF for Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial in another window
Journal Articles

A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo

Alice Banh, Nan Xiao, Hongbin Cao, Che-Hong Chen, Peiwen Kuo, Trevor Krakow, Brindha Bavan, Brian Khong, Mike Yao, Chi Ha, Michael J. Kaplan, Davud Sirjani, Kristin Jensen, Christina S. Kong, Daria Mochly-Rosen, Albert C. Koong, Quynh-Thu Le
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7265–7272.
https://doi.org/10.1158/1078-0432.CCR-11-0179
Published: 30 November 2011
View article titled, A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment <em>In Vivo</em>
Open the PDF for A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment <em>In Vivo</em> in another window
Includes: Supplementary data
Journal Articles

Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics

Edward E. Graves, Marta Vilalta, Ivana K. Cecic, Janine T. Erler, Phuoc T. Tran, Dean Felsher, Leanne Sayles, Alejandro Sweet-Cordero, Quynh-Thu Le, Amato J. Giaccia
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (19): 4843–4852.
https://doi.org/10.1158/1078-0432.CCR-10-1206
Published: 29 September 2010
View article titled, Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics
Open the PDF for Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics in another window
Includes: Supplementary data
Journal Articles

Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma

Gang Niu, Xilin Sun, Qizhen Cao, Donald Courter, Albert Koong, Quynh-Thu Le, Sanjiv Sam Gambhir, Xiaoyuan Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7): 2095–2105.
https://doi.org/10.1158/1078-0432.CCR-09-2495
Published: 31 March 2010
View article titled, Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma
Open the PDF for Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non–Small Cell Lung Cancers

Quynh-Thu Le, Eunice Chen, Ali Salim, Hongbin Cao, Christina S. Kong, Richard Whyte, Jessica Donington, Walter Cannon, Heather Wakelee, Robert Tibshirani, John D. Mitchell, Donna Richardson, Ken J. O'Byrne, Albert C. Koong, Amato J. Giaccia
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (5): 1507–1514.
https://doi.org/10.1158/1078-0432.CCR-05-2049
Published: 06 March 2006
View article titled, An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non–Small Cell Lung Cancers
Open the PDF for An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non–Small Cell Lung Cancers in another window
Journal Articles

A Comparison Study of Different PCR Assays in Measuring Circulating Plasma Epstein-Barr Virus DNA Levels in Patients with Nasopharyngeal Carcinoma

Quynh-Thu Le, Carol D. Jones, Tsz-Kok Yau, Haider A. Shirazi, Priscilla H. Wong, Ella N. Thomas, Bruce K. Patterson, Anne W.M. Lee, James L. Zehnder
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (16): 5700–5707.
https://doi.org/10.1158/1078-0432.CCR-05-0648
Published: 22 August 2005
View article titled, A Comparison Study of Different PCR Assays in Measuring Circulating Plasma Epstein-Barr Virus DNA Levels in Patients with Nasopharyngeal Carcinoma
Open the PDF for A Comparison Study of Different PCR Assays in Measuring Circulating Plasma Epstein-Barr Virus DNA Levels in Patients with Nasopharyngeal Carcinoma in another window
Journal Articles

Phase I Study of Tirapazamine Plus Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer (S0004): A Southwest Oncology Group Study

Quynh-Thu Le, Jason McCoy, Stephen Williamson, Janice Ryu, Laurie E. Gaspar, Martin J. Edelman, Shaker R. Dakhil, Stanley D. Sides, John J. Crowley, David R. Gandara
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5418–5424.
https://doi.org/10.1158/1078-0432.CCR-04-0436
Published: 24 August 2004
View article titled, Phase I Study of Tirapazamine Plus Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer (S0004): <subtitle>A Southwest Oncology Group Study</subtitle>
Open the PDF for Phase I Study of Tirapazamine Plus Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy in Limited-Stage Small Cell Lung Cancer (S0004): <subtitle>A Southwest Oncology Group Study</subtitle> in another window